Strategies for an Innovative Drug Maker to Retain its First-Mover Advantage when faced with Patent Expiry and impending Generic Competition

Strategies for an Innovative Drug Maker to Retain its First-Mover Advantage when faced with Patent Expiry and impending Generic Competition

An innovative pharmaceutical company is known to enjoy a First-Mover Advantage when it launches a patented drug in the market. However, research suggests that the edge diminishes with time. With a major patent cliff round the corner, originators are in dire need of some way to retain their once acqu...

Full description

Bibliographic Details
Main Author: Mohandas, Abhilasha
Format: Dissertation (University of Nottingham only)
Language:English
Published: 2011
Online Access:https://eprints.nottingham.ac.uk/24839/

Similar Items

Similar Items